Evogene Ownership 2024 | Who Owns Evogene Now?
Institutional Ownership
7.98%
Insider Ownership
1.66%
Retail Ownership
90.36%
Institutional Holders
27.00
Evogene Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 6.10% | 0.64% | 3,085,503 | -14,497 | -0.47% | 2,314,127 | Mar 31, 2024 |
MORGAN STANLEY | 0.56% | - | 284,048 | 95,602 | 50.73% | 213,037 | Mar 31, 2024 |
BNP PARIBAS ARBITRAGE, SNC | 0.18% | 0.00% | 91,400 | 21,500 | 30.76% | 68,550 | Mar 31, 2024 |
LPL FINANCIAL LLC | 0.13% | - | 66,835 | - | - | 50,126 | Mar 31, 2024 |
UBS GROUP AG | 0.12% | - | 62,495 | 6,490 | 11.59% | 46,871 | Mar 31, 2024 |
CITADEL ADVISORS LLC | 0.12% | - | 59,911 | 3,191 | 5.63% | 44,340 | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.12% | - | 59,007 | - | - | 43,671 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.09% | 0.00% | 44,800 | - | - | 34,000 | Mar 31, 2024 |
JPMORGAN CHASE & CO | 0.08% | - | 39,430 | -25,164 | -38.96% | 29,573 | Mar 31, 2024 |
PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 38,034 | 15,748 | 70.66% | 28,526,000 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.06% | - | 32,495 | 32,495 | 100.00% | 24,050 | Mar 31, 2024 |
SIGMA PLANNING CORP | 0.06% | 0.00% | 31,785 | 8,698 | 37.67% | 23,839 | Mar 31, 2024 |
CSENGE ADVISORY GROUP | 0.06% | 0.00% | 30,762 | - | - | 23,067 | Mar 31, 2024 |
JOEL ISAACSON & CO., LLC | 0.06% | 0.00% | 30,300 | - | - | 22,725 | Mar 31, 2024 |
CITADEL ADVISORS LLC | 0.05% | - | 23,000 | 23,000 | 100.00% | 17,022 | Mar 31, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 10,510 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | 13,321 | 100.00% | 9,859 | Mar 31, 2024 |
MALAGA COVE CAPITAL, LLC | 0.02% | 0.00% | 12,000 | - | - | 9,000 | Mar 31, 2024 |
XTX TOPCO LTD | 0.02% | 0.00% | 11,561 | 11,561 | 100.00% | 8,556 | Mar 31, 2024 |
COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | - | 11,089 | 11,089 | 100.00% | 8,000 | Mar 31, 2024 |
Evogene's largest institutional shareholder is SILVERARC CAPITAL MANAGEMENT, LLC, holding 6.10% of the company's total share outstanding, currently valued at $2.31M. The top 10 institutional shareholders own together 7.57% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 6.10% | 0.64% | 3,085,503 | -14,497 | -0.47% | 2,314,127 | Mar 31, 2024 |
MALAGA COVE CAPITAL, LLC | 0.02% | 0.00% | 12,000 | - | - | 9,000 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | 13,321 | 100.00% | 9,859 | Mar 31, 2024 |
CSENGE ADVISORY GROUP | 0.06% | 0.00% | 30,762 | - | - | 23,067 | Mar 31, 2024 |
JOEL ISAACSON & CO., LLC | 0.06% | 0.00% | 30,300 | - | - | 22,725 | Mar 31, 2024 |
XTX TOPCO LTD | 0.02% | 0.00% | 11,561 | 11,561 | 100.00% | 8,556 | Mar 31, 2024 |
SIGMA PLANNING CORP | 0.06% | 0.00% | 31,785 | 8,698 | 37.67% | 23,839 | Mar 31, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 10,510 | Mar 31, 2024 |
BNP PARIBAS ARBITRAGE, SNC | 0.18% | 0.00% | 91,400 | 21,500 | 30.76% | 68,550 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.09% | 0.00% | 44,800 | - | - | 34,000 | Mar 31, 2024 |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 5,000 | - | - | 3,750 | Mar 31, 2024 |
0.01% | - | 5,000 | 5,000 | 100.00% | 3,750 | Mar 31, 2024 | |
LPL FINANCIAL LLC | 0.13% | - | 66,835 | - | - | 50,126 | Mar 31, 2024 |
PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 38,034 | 15,748 | 70.66% | 28,526,000 | Mar 31, 2024 |
MORGAN STANLEY | 0.56% | - | 284,048 | 95,602 | 50.73% | 213,037 | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.02% | - | 8,425 | - | - | 6,319,000 | Mar 31, 2024 |
COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | - | 11,089 | 11,089 | 100.00% | 8,000 | Mar 31, 2024 |
UBS GROUP AG | 0.12% | - | 62,495 | 6,490 | 11.59% | 46,871 | Mar 31, 2024 |
CITADEL ADVISORS LLC | 0.12% | - | 59,911 | 3,191 | 5.63% | 44,340 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.06% | - | 32,495 | 32,495 | 100.00% | 24,050 | Mar 31, 2024 |
The largest Evogene shareholder by % of total assets is SILVERARC CAPITAL MANAGEMENT, LLC. The company owns 3.09M shares of Evogene (EVGN), representing 0.64% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MORGAN STANLEY | 0.56% | - | 284,048 | 95,602 | 50.73% | 213,037 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.06% | - | 32,495 | 32,495 | 100.00% | 24,050 | Mar 31, 2024 |
CITADEL ADVISORS LLC | 0.05% | - | 23,000 | 23,000 | 100.00% | 17,022 | Mar 31, 2024 |
BNP PARIBAS ARBITRAGE, SNC | 0.18% | 0.00% | 91,400 | 21,500 | 30.76% | 68,550 | Mar 31, 2024 |
PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 38,034 | 15,748 | 70.66% | 28,526,000 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | 13,321 | 100.00% | 9,859 | Mar 31, 2024 |
XTX TOPCO LTD | 0.02% | 0.00% | 11,561 | 11,561 | 100.00% | 8,556 | Mar 31, 2024 |
COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | - | 11,089 | 11,089 | 100.00% | 8,000 | Mar 31, 2024 |
SIGMA PLANNING CORP | 0.06% | 0.00% | 31,785 | 8,698 | 37.67% | 23,839 | Mar 31, 2024 |
UBS GROUP AG | 0.12% | - | 62,495 | 6,490 | 11.59% | 46,871 | Mar 31, 2024 |
0.01% | - | 5,000 | 5,000 | 100.00% | 3,750 | Mar 31, 2024 | |
CITADEL ADVISORS LLC | 0.12% | - | 59,911 | 3,191 | 5.63% | 44,340 | Mar 31, 2024 |
TORONTO DOMINION BANK | - | - | 20 | - | - | 15 | Mar 31, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 50 | - | - | 37 | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.12% | - | 59,007 | - | - | 43,671 | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.02% | - | 8,425 | - | - | 6,319,000 | Mar 31, 2024 |
LPL FINANCIAL LLC | 0.13% | - | 66,835 | - | - | 50,126 | Mar 31, 2024 |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 5,000 | - | - | 3,750 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.09% | 0.00% | 44,800 | - | - | 34,000 | Mar 31, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 10,510 | Mar 31, 2024 |
As of Mar 31 2024, Evogene's largest institutional buyer is MORGAN STANLEY. The company purchased 95.60K stocks of EVGN, valued at $213.04K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WALLEYE CAPITAL LLC | - | - | - | -349,477 | -100.00% | - | Mar 31, 2024 |
CONNECTIVE CAPITAL MANAGEMENT, LLC | - | - | - | -100,000 | -100.00% | - | Mar 31, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -34,074 | -100.00% | - | Mar 31, 2024 |
JPMORGAN CHASE & CO | 0.08% | - | 39,430 | -25,164 | -38.96% | 29,573 | Mar 31, 2024 |
SILVERARC CAPITAL MANAGEMENT, LLC | 6.10% | 0.64% | 3,085,503 | -14,497 | -0.47% | 2,314,127 | Mar 31, 2024 |
TWO SIGMA SECURITIES, LLC | - | - | - | -12,373 | -100.00% | - | Mar 31, 2024 |
SNS FINANCIAL GROUP, LLC | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
CUTLER GROUP LLC / CA | - | - | - | -2,600 | -100.00% | - | Mar 31, 2024 |
CITADEL ADVISORS LLC | - | - | - | -2,100 | -100.00% | - | Mar 31, 2024 |
GROUP ONE TRADING, L.P. | 0.00% | - | 126 | -1,001 | -88.82% | 93 | Mar 31, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 1,074 | -274 | -20.33% | 806,000 | Mar 31, 2024 |
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -100 | -100.00% | - | Mar 31, 2024 |
MALAGA COVE CAPITAL, LLC | 0.02% | 0.00% | 12,000 | - | - | 9,000 | Mar 31, 2024 |
CSENGE ADVISORY GROUP | 0.06% | 0.00% | 30,762 | - | - | 23,067 | Mar 31, 2024 |
JOEL ISAACSON & CO., LLC | 0.06% | 0.00% | 30,300 | - | - | 22,725 | Mar 31, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 10,510 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.09% | 0.00% | 44,800 | - | - | 34,000 | Mar 31, 2024 |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 5,000 | - | - | 3,750 | Mar 31, 2024 |
LPL FINANCIAL LLC | 0.13% | - | 66,835 | - | - | 50,126 | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.02% | - | 8,425 | - | - | 6,319,000 | Mar 31, 2024 |
As of Mar 31 2024, Evogene's biggest institutional seller is WALLEYE CAPITAL LLC. The company sold -0.35M shares of EVGN, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.06% | - | 32,495 | 32,495 | 100.00% | 24,050 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | 13,321 | 100.00% | 9,859 | Mar 31, 2024 |
XTX TOPCO LTD | 0.02% | 0.00% | 11,561 | 11,561 | 100.00% | 8,556 | Mar 31, 2024 |
COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | - | 11,089 | 11,089 | 100.00% | 8,000 | Mar 31, 2024 |
0.01% | - | 5,000 | 5,000 | 100.00% | 3,750 | Mar 31, 2024 |
Evogene's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 32.49K shares, valued at $24.05K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WALLEYE CAPITAL LLC | - | - | - | -349,477 | -100.00% | - | Mar 31, 2024 |
CONNECTIVE CAPITAL MANAGEMENT, LLC | - | - | - | -100,000 | -100.00% | - | Mar 31, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -34,074 | -100.00% | - | Mar 31, 2024 |
TWO SIGMA SECURITIES, LLC | - | - | - | -12,373 | -100.00% | - | Mar 31, 2024 |
SNS FINANCIAL GROUP, LLC | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
CUTLER GROUP LLC / CA | - | - | - | -2,600 | -100.00% | - | Mar 31, 2024 |
CITADEL ADVISORS LLC | - | - | - | -2,100 | -100.00% | - | Mar 31, 2024 |
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -100 | -100.00% | - | Mar 31, 2024 |
Evogene's largest sold out institutional shareholder by shares sold is WALLEYE CAPITAL LLC, sold -0.35M shares, valued at -, as of undefined.
Evogene Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 3,768 | - | - | Dec 31, 2023 |
Evogene's largest mutual fund holder by % of total assets is "JOHN HANCOCK VARIABLE INSURANCE TRUST", owning 3.77K shares, compromising 0.00% of its total assets.
Evogene Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 27 | -6.90% |
31 Dec, 23 | 29 | -9.38% |
30 Sep, 23 | 32 | 28.00% |
30 Jun, 23 | 25 | 4.17% |
31 Mar, 23 | 24 | -7.69% |
31 Dec, 22 | 26 | 13.04% |
30 Sep, 22 | 23 | -14.81% |
30 Jun, 22 | 27 | -22.86% |
31 Mar, 22 | 35 | -10.26% |
31 Dec, 21 | 39 | - |
30 Sep, 21 | 39 | -9.30% |
30 Jun, 21 | 43 | -10.42% |
31 Mar, 21 | 48 | 60.00% |
31 Dec, 20 | 30 | 87.50% |
30 Sep, 20 | 16 | - |
30 Jun, 20 | 16 | 6.67% |
31 Mar, 20 | 15 | - |
31 Dec, 19 | 15 | -11.76% |
30 Sep, 19 | 17 | - |
30 Jun, 19 | 17 | -19.05% |
31 Mar, 19 | 21 | -8.70% |
31 Dec, 18 | 23 | - |
30 Sep, 18 | 23 | - |
30 Jun, 18 | 23 | -8.00% |
31 Mar, 18 | 25 | 4.17% |
31 Dec, 17 | 24 | 33.33% |
30 Sep, 17 | 18 | -14.29% |
30 Jun, 17 | 21 | -4.55% |
31 Mar, 17 | 22 | - |
31 Dec, 16 | 22 | 22.22% |
30 Sep, 16 | 18 | - |
30 Jun, 16 | 18 | -14.29% |
31 Mar, 16 | 21 | 10.53% |
31 Dec, 15 | 19 | 5.56% |
30 Sep, 15 | 18 | - |
30 Jun, 15 | 18 | 12.50% |
31 Mar, 15 | 16 | 6.67% |
31 Dec, 14 | 15 | - |
30 Sep, 14 | 15 | - |
30 Jun, 14 | 15 | -16.67% |
31 Mar, 14 | 18 | 5.88% |
31 Dec, 13 | 17 | - |
As of 31 Mar 24, 27 institutions are holding Evogene's shares, representing a decrease of -6.90% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 4,038,484 | -5.27% |
31 Dec, 23 | 4,263,376 | -2.82% |
30 Sep, 23 | 4,387,025 | 532.01% |
30 Jun, 23 | 694,139 | -9.69% |
31 Mar, 23 | 768,577 | -27.69% |
31 Dec, 22 | 1,062,917 | -26.04% |
30 Sep, 22 | 1,437,075 | -7.87% |
30 Jun, 22 | 1,559,836 | -34.64% |
31 Mar, 22 | 2,386,650 | -59.71% |
31 Dec, 21 | 5,923,403 | -4.21% |
30 Sep, 21 | 6,183,963 | -15.53% |
30 Jun, 21 | 7,321,262 | -11.71% |
31 Mar, 21 | 8,292,075 | -12.83% |
31 Dec, 20 | 9,512,413 | 12.20% |
30 Sep, 20 | 8,478,173 | 36.82% |
30 Jun, 20 | 6,196,365 | -15.26% |
31 Mar, 20 | 7,312,420 | 8.55% |
31 Dec, 19 | 6,736,377 | -10.44% |
30 Sep, 19 | 7,521,386 | -0.08% |
30 Jun, 19 | 7,527,241 | -13.25% |
31 Mar, 19 | 8,676,785 | -4.81% |
31 Dec, 18 | 9,115,525 | 0.23% |
30 Sep, 18 | 9,094,703 | 0.30% |
30 Jun, 18 | 9,067,253 | -1.47% |
31 Mar, 18 | 9,202,857 | -0.20% |
31 Dec, 17 | 9,220,844 | 15.74% |
30 Sep, 17 | 7,966,801 | -0.76% |
30 Jun, 17 | 8,027,421 | 2.84% |
31 Mar, 17 | 7,805,502 | 1.31% |
31 Dec, 16 | 7,704,367 | 1.28% |
30 Sep, 16 | 7,606,646 | 1.61% |
30 Jun, 16 | 7,486,335 | 2.04% |
31 Mar, 16 | 7,336,690 | 4.07% |
31 Dec, 15 | 7,049,473 | 10.48% |
30 Sep, 15 | 6,380,810 | 1.92% |
30 Jun, 15 | 6,260,311 | 5.66% |
31 Mar, 15 | 5,925,046 | 4.97% |
31 Dec, 14 | 5,644,727 | 13.97% |
30 Sep, 14 | 4,952,851 | 21.13% |
30 Jun, 14 | 4,088,931 | -0.58% |
31 Mar, 14 | 4,112,706 | -15.61% |
31 Dec, 13 | 4,873,504 | - |
Evogene (EVGN) has 4.04M shares outstanding as of 31 Mar 24, down -5.27% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 7.98% | 10.51% |
31 Dec, 23 | 8.71% | 7.85% |
30 Sep, 23 | 10.53% | 376.34% |
30 Jun, 23 | 1.67% | 48.75% |
31 Mar, 23 | 1.85% | 27.84% |
31 Dec, 22 | 2.58% | 21.21% |
30 Sep, 22 | 3.49% | 24.33% |
30 Jun, 22 | 3.79% | 11.27% |
31 Mar, 22 | 5.79% | 2.80% |
31 Dec, 21 | 14.39% | 6.28% |
30 Sep, 21 | 15.14% | 4.65% |
30 Jun, 21 | 18.04% | 3.98% |
31 Mar, 21 | 21.28% | 2.74% |
31 Dec, 20 | 27.89% | 2.82% |
30 Sep, 20 | 31.43% | 5.43% |
30 Jun, 20 | 24.06% | 2.98% |
31 Mar, 20 | 28.39% | 4.15% |
31 Dec, 19 | 26.16% | 3.07% |
30 Sep, 19 | 29.20% | 3.42% |
30 Jun, 19 | 29.23% | 2.57% |
31 Mar, 19 | 33.69% | 2.69% |
31 Dec, 18 | 35.40% | 2.84% |
30 Sep, 18 | 35.31% | 2.85% |
30 Jun, 18 | 35.21% | 2.76% |
31 Mar, 18 | 35.74% | 2.78% |
31 Dec, 17 | 35.84% | 3.56% |
30 Sep, 17 | 31.71% | 3.42% |
30 Jun, 17 | 30.46% | 3.25% |
31 Mar, 17 | 30.60% | 3.37% |
31 Dec, 16 | 30.15% | 3.41% |
30 Sep, 16 | 29.75% | 3.26% |
30 Jun, 16 | 30.19% | 3.77% |
31 Mar, 16 | 28.29% | 3.65% |
31 Dec, 15 | 27.85% | 4.63% |
30 Sep, 15 | 24.53% | 3.83% |
30 Jun, 15 | 25.29% | 4.95% |
31 Mar, 15 | 22.59% | 4.45% |
31 Dec, 14 | 22.53% | 5.55% |
30 Sep, 14 | 20.15% | 7.26% |
30 Jun, 14 | 16.66% | 6.09% |
31 Mar, 14 | 16.54% | 3.10% |
31 Dec, 13 | 23.11% | - |
As of 31 Mar 24, Evogene is held by 7.98% institutional shareholders, representing a 10.51% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | 11 | 83.33% |
31 Dec, 23 | 6 | -66.67% |
30 Sep, 23 | 18 | 50.00% |
30 Jun, 23 | 12 | 50.00% |
31 Mar, 23 | 8 | -20.00% |
31 Dec, 22 | 10 | 42.86% |
30 Sep, 22 | 7 | 16.67% |
30 Jun, 22 | 6 | -45.45% |
31 Mar, 22 | 11 | -45.00% |
31 Dec, 21 | 20 | 66.67% |
30 Sep, 21 | 12 | -29.41% |
30 Jun, 21 | 17 | -50.00% |
31 Mar, 21 | 34 | 41.67% |
31 Dec, 20 | 24 | 118.18% |
30 Sep, 20 | 11 | 57.14% |
30 Jun, 20 | 7 | 40.00% |
31 Mar, 20 | 5 | 400.00% |
31 Dec, 19 | 1 | -80.00% |
30 Sep, 19 | 5 | 25.00% |
30 Jun, 19 | 4 | -50.00% |
31 Mar, 19 | 8 | 14.29% |
31 Dec, 18 | 7 | -22.22% |
30 Sep, 18 | 9 | 12.50% |
30 Jun, 18 | 8 | 14.29% |
31 Mar, 18 | 7 | -50.00% |
31 Dec, 17 | 14 | 100.00% |
30 Sep, 17 | 7 | - |
30 Jun, 17 | 7 | -22.22% |
31 Mar, 17 | 9 | -10.00% |
31 Dec, 16 | 10 | 66.67% |
30 Sep, 16 | 6 | -14.29% |
30 Jun, 16 | 7 | -36.36% |
31 Mar, 16 | 11 | - |
31 Dec, 15 | 11 | 22.22% |
30 Sep, 15 | 9 | 12.50% |
30 Jun, 15 | 8 | 60.00% |
31 Mar, 15 | 5 | -28.57% |
31 Dec, 14 | 7 | 16.67% |
30 Sep, 14 | 6 | 100.00% |
30 Jun, 14 | 3 | -50.00% |
31 Mar, 14 | 6 | -64.71% |
31 Dec, 13 | 17 | - |
11 institutional shareholders have increased their position in EVGN stock as of 31 Mar 24 compared to 6 in the previous quarter (a 83.33% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | 4 | -42.86% |
31 Dec, 23 | 7 | 75.00% |
30 Sep, 23 | 4 | -20.00% |
30 Jun, 23 | 5 | -16.67% |
31 Mar, 23 | 6 | 20.00% |
31 Dec, 22 | 5 | - |
30 Sep, 22 | 5 | -58.33% |
30 Jun, 22 | 12 | 20.00% |
31 Mar, 22 | 10 | 11.11% |
31 Dec, 21 | 9 | -47.06% |
30 Sep, 21 | 17 | - |
30 Jun, 21 | 17 | 325.00% |
31 Mar, 21 | 4 | - |
31 Dec, 20 | 4 | -20.00% |
30 Sep, 20 | 5 | 25.00% |
30 Jun, 20 | 4 | 100.00% |
31 Mar, 20 | 2 | -71.43% |
31 Dec, 19 | 7 | 133.33% |
30 Sep, 19 | 3 | -50.00% |
30 Jun, 19 | 6 | 20.00% |
31 Mar, 19 | 5 | 25.00% |
31 Dec, 18 | 4 | 33.33% |
30 Sep, 18 | 3 | - |
30 Jun, 18 | 3 | -57.14% |
31 Mar, 18 | 7 | 250.00% |
31 Dec, 17 | 2 | - |
30 Sep, 17 | 2 | -33.33% |
30 Jun, 17 | 3 | -25.00% |
31 Mar, 17 | 4 | -20.00% |
31 Dec, 16 | 5 | 66.67% |
30 Sep, 16 | 3 | - |
30 Jun, 16 | 3 | -40.00% |
31 Mar, 16 | 5 | - |
31 Dec, 15 | - | -100.00% |
30 Sep, 15 | 2 | - |
30 Jun, 15 | 2 | -33.33% |
31 Mar, 15 | 3 | -25.00% |
31 Dec, 14 | 4 | -20.00% |
30 Sep, 14 | 5 | -28.57% |
30 Jun, 14 | 7 | -22.22% |
31 Mar, 14 | 9 | - |
31 Dec, 13 | - | - |
4 institutional shareholders have reduced their position in EVGN stock as of 31 Mar 24 compared to 7 in the previous quarter (a -42.86% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 27 | -6.90% | 4,038,484 | -5.27% | 7.98% | 10.51% | 11 | 83.33% | 4 | -42.86% |
31 Dec, 23 | 29 | -9.38% | 4,263,376 | -2.82% | 8.71% | 7.85% | 6 | -66.67% | 7 | 75.00% |
30 Sep, 23 | 32 | 28.00% | 4,387,025 | 532.01% | 10.53% | 376.34% | 18 | 50.00% | 4 | -20.00% |
30 Jun, 23 | 25 | 4.17% | 694,139 | -9.69% | 1.67% | 48.75% | 12 | 50.00% | 5 | -16.67% |
31 Mar, 23 | 24 | -7.69% | 768,577 | -27.69% | 1.85% | 27.84% | 8 | -20.00% | 6 | 20.00% |
31 Dec, 22 | 26 | 13.04% | 1,062,917 | -26.04% | 2.58% | 21.21% | 10 | 42.86% | 5 | - |
30 Sep, 22 | 23 | -14.81% | 1,437,075 | -7.87% | 3.49% | 24.33% | 7 | 16.67% | 5 | -58.33% |
30 Jun, 22 | 27 | -22.86% | 1,559,836 | -34.64% | 3.79% | 11.27% | 6 | -45.45% | 12 | 20.00% |
31 Mar, 22 | 35 | -10.26% | 2,386,650 | -59.71% | 5.79% | 2.80% | 11 | -45.00% | 10 | 11.11% |
31 Dec, 21 | 39 | - | 5,923,403 | -4.21% | 14.39% | 6.28% | 20 | 66.67% | 9 | -47.06% |
30 Sep, 21 | 39 | -9.30% | 6,183,963 | -15.53% | 15.14% | 4.65% | 12 | -29.41% | 17 | - |
30 Jun, 21 | 43 | -10.42% | 7,321,262 | -11.71% | 18.04% | 3.98% | 17 | -50.00% | 17 | 325.00% |
31 Mar, 21 | 48 | 60.00% | 8,292,075 | -12.83% | 21.28% | 2.74% | 34 | 41.67% | 4 | - |
31 Dec, 20 | 30 | 87.50% | 9,512,413 | 12.20% | 27.89% | 2.82% | 24 | 118.18% | 4 | -20.00% |
30 Sep, 20 | 16 | - | 8,478,173 | 36.82% | 31.43% | 5.43% | 11 | 57.14% | 5 | 25.00% |
30 Jun, 20 | 16 | 6.67% | 6,196,365 | -15.26% | 24.06% | 2.98% | 7 | 40.00% | 4 | 100.00% |
31 Mar, 20 | 15 | - | 7,312,420 | 8.55% | 28.39% | 4.15% | 5 | 400.00% | 2 | -71.43% |
31 Dec, 19 | 15 | -11.76% | 6,736,377 | -10.44% | 26.16% | 3.07% | 1 | -80.00% | 7 | 133.33% |
30 Sep, 19 | 17 | - | 7,521,386 | -0.08% | 29.20% | 3.42% | 5 | 25.00% | 3 | -50.00% |
30 Jun, 19 | 17 | -19.05% | 7,527,241 | -13.25% | 29.23% | 2.57% | 4 | -50.00% | 6 | 20.00% |
31 Mar, 19 | 21 | -8.70% | 8,676,785 | -4.81% | 33.69% | 2.69% | 8 | 14.29% | 5 | 25.00% |
31 Dec, 18 | 23 | - | 9,115,525 | 0.23% | 35.40% | 2.84% | 7 | -22.22% | 4 | 33.33% |
30 Sep, 18 | 23 | - | 9,094,703 | 0.30% | 35.31% | 2.85% | 9 | 12.50% | 3 | - |
30 Jun, 18 | 23 | -8.00% | 9,067,253 | -1.47% | 35.21% | 2.76% | 8 | 14.29% | 3 | -57.14% |
31 Mar, 18 | 25 | 4.17% | 9,202,857 | -0.20% | 35.74% | 2.78% | 7 | -50.00% | 7 | 250.00% |
31 Dec, 17 | 24 | 33.33% | 9,220,844 | 15.74% | 35.84% | 3.56% | 14 | 100.00% | 2 | - |
30 Sep, 17 | 18 | -14.29% | 7,966,801 | -0.76% | 31.71% | 3.42% | 7 | - | 2 | -33.33% |
30 Jun, 17 | 21 | -4.55% | 8,027,421 | 2.84% | 30.46% | 3.25% | 7 | -22.22% | 3 | -25.00% |
31 Mar, 17 | 22 | - | 7,805,502 | 1.31% | 30.60% | 3.37% | 9 | -10.00% | 4 | -20.00% |
31 Dec, 16 | 22 | 22.22% | 7,704,367 | 1.28% | 30.15% | 3.41% | 10 | 66.67% | 5 | 66.67% |
30 Sep, 16 | 18 | - | 7,606,646 | 1.61% | 29.75% | 3.26% | 6 | -14.29% | 3 | - |
30 Jun, 16 | 18 | -14.29% | 7,486,335 | 2.04% | 30.19% | 3.77% | 7 | -36.36% | 3 | -40.00% |
31 Mar, 16 | 21 | 10.53% | 7,336,690 | 4.07% | 28.29% | 3.65% | 11 | - | 5 | - |
31 Dec, 15 | 19 | 5.56% | 7,049,473 | 10.48% | 27.85% | 4.63% | 11 | 22.22% | - | -100.00% |
30 Sep, 15 | 18 | - | 6,380,810 | 1.92% | 24.53% | 3.83% | 9 | 12.50% | 2 | - |
30 Jun, 15 | 18 | 12.50% | 6,260,311 | 5.66% | 25.29% | 4.95% | 8 | 60.00% | 2 | -33.33% |
31 Mar, 15 | 16 | 6.67% | 5,925,046 | 4.97% | 22.59% | 4.45% | 5 | -28.57% | 3 | -25.00% |
31 Dec, 14 | 15 | - | 5,644,727 | 13.97% | 22.53% | 5.55% | 7 | 16.67% | 4 | -20.00% |
30 Sep, 14 | 15 | - | 4,952,851 | 21.13% | 20.15% | 7.26% | 6 | 100.00% | 5 | -28.57% |
30 Jun, 14 | 15 | -16.67% | 4,088,931 | -0.58% | 16.66% | 6.09% | 3 | -50.00% | 7 | -22.22% |
31 Mar, 14 | 18 | 5.88% | 4,112,706 | -15.61% | 16.54% | 3.10% | 6 | -64.71% | 9 | - |
31 Dec, 13 | 17 | - | 4,873,504 | - | 23.11% | - | 17 | - | - | - |
Evogene Peer Ownership
Ticker | Company |
---|---|
LEXX | Lexaria Bioscience Corp. |
ZVSA | ZyVersa Therapeutics, Inc. |
CKPT | Checkpoint Therapeutics, Inc. |
BDRX | Biodexa Pharmaceuticals Plc |
FATE | Fate Therapeutics, Inc. |
PLUR | Pluri Inc. |
CGEN | Compugen Ltd. |
GMDA | Gamida Cell Ltd. |
CLGN | CollPlant Biotechnologies Ltd. |
ONCR | Oncorus, Inc. |
CRVS | Corvus Pharmaceuticals, Inc. |
RCUS | Arcus Biosciences, Inc. |
SURF | Surface Oncology, Inc. |
ALDX | Aldeyra Therapeutics, Inc. |
ICCC | ImmuCell Corporation |
EVGN Ownership FAQ
Who Owns Evogene?
Evogene is owned by institutional shareholders (7.98%), insiders (1.66%), and public (90.36%). The largest institutional shareholder of Evogene is SILVERARC CAPITAL MANAGEMENT, LLC (6.10% of total shares) and the top mutual fund owner is JOHN HANCOCK VARIABLE INSURANCE TRUST (0.00% of total shares).
Who are the major institutional shareholders of Evogene?
Evogene's major institutional shareholders are SILVERARC CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SNC, LPL FINANCIAL LLC, and UBS GROUP AG. The top five shareholders own together 7.10% of the company's share outstanding.
How many Evogene shareholders are there?
As of Mar 2024, there are 27 institutional shareholders of Evogene.
What percentage of Evogene is owned by SILVERARC CAPITAL MANAGEMENT, LLC?
SILVERARC CAPITAL MANAGEMENT, LLC owns 3.09M shares of Evogene, representing 6.10% of the company's total shares outstanding, valued at $2.31M (as of Mar 2024).
What percentage of Evogene is owned by MORGAN STANLEY?
As of Mar 2024, MORGAN STANLEY holds 284.05K shares of Evogene (EVGN), compromising 0.56% of the company, valued at $213.04K.
What percentage of Evogene is owned by BNP PARIBAS ARBITRAGE, SNC?
BNP PARIBAS ARBITRAGE, SNC is the third largest holder of Evogene. The company owns 91.4K of the company's shares outstanding (worth $68.55K).